Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 8457

Evolutionary Medicine — Linking human pathology with our past, present, and future evolutionary trajectories — ideaXme (http://radioideaxme.com/) welcomes Prof. Dr. Frank Rühli, Director of the Institute of Evolutionary Medicine, University of Zurich — #Ideaxme #EvolutionaryMedicine #Evolution #Microevolution #Paleopathology #BiologicalAnthropology #ComparativeAnatomy #Mummies #Mummy #Hypercholesterinemia #Diabetes #DrugAddiction #Health #Wellness #Regeneration #Longevity #Aging #IraPastor #Bioquark #Regenerage

Ira Pastor, ideaXme exponential health ambassador, interviews Professor Dr. Frank Rühli, Director of the Institute of Evolutionary Medicine and on the Medical Faculty of University of Zurich, and Founding Director, Chair, Full Professor of Evolutionary Medicine.

Ira Pastor Comments

Continue reading “The Health Past Of Mummies: Evolutionary Medicine Insights For Human Diseases Now” | >

Well, it’s a good thing, but not what I was hoping for. 3 gene therapies though Church is otherwise testing 45. But this is not the rejuvenation I was getting optimistic about. Still, I’m sure as I am getting older that I will be grateful when a treatment comes my way for something when I am elderly. But frankly this was overhyped from the start and I was part of that equation spreading a “2025” figure for some time.

Gene Therapy.

An ‘anti-aging’ gene therapy trial in dogs begins, and Rejuvenate Bio hopes humans will be next.

The startup, spun out of George Church’s lab, has tested an experimental therapy that treats four age-related diseases in mice.

Continue reading “An ‘anti-aging’ gene therapy trial in dogs begins, and Rejuvenate Bio hopes humans will be next” | >

Drugmaker Johnson & Johnson is “pretty confident” that it can create a vaccine to combat the deadly coronavirus, an exec said Monday.

Paul Stoffels, the company’s chief scientific officer, said it began working on a vaccine two weeks ago — and is hopeful that it can be developed within months, CNBC reported.

“We have dozens of scientists working on this so we’re pretty confident we can get something made that will work and stay active for the longer term,” Stoffels told CNBC’s “Squawk Box.”

Read more | >

Even though we are led to believe that during the Cretaceous the Earth used to be an exclusive home for fearsome giants, including carnivorous velociraptors and arthropods larger than a modern adult human, it turns out that there was still room for harmless minute invertebrates measuring only several millimetres.

Such is the case of a tiny millipede of only 8.2 mm in length, recently found in 99-million-year-old amber in Myanmar. Using the latest research technologies, the scientists concluded that not only were they handling the first fossil millipede of the order (Callipodida) and also the smallest amongst its contemporary relatives, but that its morphology was so unusual that it drastically deviated from its contemporary relatives.

As a result, Prof. Pavel Stoev of the National Museum of Natural History (Bulgaria) together with his colleagues Dr. Thomas Wesener and Leif Moritz of the Zoological Research Museum Alexander Koenig (Germany) had to revise the current millipede classification and introduce a new suborder. To put it in perspective, there have only been a handful of millipede suborders erected in the last 50 years. The findings are published in the open-access journal ZooKeys.

Read more | >

Gilead Sciences said it is sending an experimental antiviral drug to China for emergency treatment of coronavirus patients as well as testing to see if it works against the virus.

Gilead Sciences Inc. said on Friday that it had provided doses of an experimental antiviral drug to doctors for the emergency treatment of a small number of patients infected by the new coronavirus.

Read more | >

Did product safety laws lead to the dumbing down of science toys?

“Users should not take ore samples out of their jars, for they tend to flake and crumble and you would run the risk of having radioactive ore spread out in your laboratory.” Such was the warning that came with the Gilbert U-238 Atomic Energy Lab, a 1950s science kit that included four small jars of actual uranium. Budding young nuclear scientists were encouraged to use the enclosed instruments to measure the samples’ radioactivity, observe radioactive decay, and even go prospecting for radioactive ores. Yes, the Gilbert company definitely intended for kids to try this at home. And so the company’s warning was couched not in terms of health risk but rather as bad scientific practice: Removing the ore from its jar would raise the background radiation, thereby invalidating your experimental results.

The Gilbert U-238 Atomic Energy Lab put a positive spin on radioactivity

Continue reading “Fun—and Uranium—for the Whole Family in This 1950s Science Kit” | >